IEX Add to watchlist $199.43 5.47 (-2.67%) Last updated: Apr 16, 2026 00:39
52-Week Range
$199.43
$157.25 $199.43 $217.16

Fundamentals Overview

IDEX Corporation is in the middle of its 52-week range with premium valuation, trending downward today.

Valuation premium

P/E 30.9 P/B 3.7 P/S 4.29

Intrinsic value (DCF)

+20.1% upside vs price

Profitability

Net margin 14%

Risk (Beta)

0.98 — in line vol

Earnings & growth

EPS $6.46 Rev +2.3% Profit +0.4% vs prior qtr

BullzEye Analysis

Our composite tilts Buy on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Buy — 74% confidence Risk: Moderate Volatility — Beta 0.98. Diversify and only invest what you can afford to lose.

Supporting (Buy):

DCF +20.1% upside vs price · Analyst grade: B · Sentiment improving (1 upgrade) · 3M vs S&P 500: +6.4%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$14.83B
P/E (TTM)
30.87
EPS (TTM)
$6.46
Dividend Yield
0.36%
52-Week Range
$157.25 - $217.16
Volume vs Avg
N/A
Beta
0.98

About

IDEX Corporation, together with its subsidiaries, provides applied solutions worldwide. The company operates through three segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT segment designs, produces, and distributes positive displacement pumps, small volume provers, flow meters, injectors, and other fluid-handling pump modules and systems, as well as offers flow monitoring and other services for the food, ch...
Sector: Industrials
Headquarters: US
Employees: 9,000
IPO Date: Jun 1989
Beta: 0.98 (Less volatile than market)

Ratings & Grades at a Glance

Overall rating: B. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 16, Market Perform: 1, Neutral: 3, Outperform: 10.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $239.50; current price is $199.43. That’s a +20.1% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 30.87
DCF value (model) $239.50 (20.1% upside)
PEG (TTM) N/A
P/B (TTM) 3.7
P/S (TTM) 4.29
P/FCF (TTM) 24.04
Liquidity & enterprise
Current Ratio (TTM) 2.86
Quick Ratio (TTM) 2.02
Cash Ratio (TTM) 1.01
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 13.98%
Gross margin (TTM) 44.51%
Operating margin (TTM) 20.89%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for IEX.

Analyst Sentiment at a Glance

B Sentiment Improving
Buy 16Market Perform 1Neutral 3Outperform 10
1 upgrade, 0 downgrades
Price Target Consensus
Current $199.43
Median $240.00
Consensus $236.57
Low consensus $214.00
High consensus $247.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
BMO Capital maintain Market Perform Market Perform 2026-03-27
Argus Research upgrade Hold Buy 2026-02-06
DA Davidson maintain Neutral Neutral 2026-02-05
RBC Capital maintain Outperform Outperform 2026-02-05
Citigroup maintain Buy Buy 2026-02-05
TD Cowen maintain Buy Buy 2026-02-05
Stifel maintain Buy Buy 2026-01-23
Citigroup maintain Buy Buy 2025-12-08
RBC Capital maintain Outperform Outperform 2025-10-30
Stifel maintain Buy Buy 2025-10-20
Oppenheimer maintain Outperform Outperform 2025-10-07
DA Davidson maintain Neutral Neutral 2025-08-04
Stifel maintain Buy Buy 2025-07-31
Oppenheimer maintain Outperform Outperform 2025-07-31
RBC Capital maintain Outperform Outperform 2025-07-31
Stifel maintain Buy Buy 2025-07-21
Citigroup maintain Buy Buy 2025-07-14
RBC Capital maintain Outperform Outperform 2025-05-02
Stifel maintain Buy Buy 2025-05-02
Citigroup maintain Buy Buy 2025-04-14
Stifel maintain Buy Buy 2025-04-14
DA Davidson maintain Neutral Neutral 2025-02-19
RBC Capital maintain Outperform Outperform 2025-02-06
Citigroup maintain Buy Buy 2025-01-13
Stifel maintain Buy Buy 2024-12-11
Citigroup maintain Buy Buy 2024-12-09
RBC Capital maintain Outperform Outperform 2024-12-06
RBC Capital maintain Outperform Outperform 2024-10-31
Baird maintain Outperform Outperform 2024-10-31
Stifel maintain Buy Buy 2024-10-16